Fecal Occult Testing Market: By Product, By End User and Region Forecast 2019-2030  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Fecal Occult Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, and Immuno-FOB ELISA Test), By End User (Hospitals, Clinical Diagnostic Laboratories, and Physicians Office Laboratories) and Region Forecast 2019-2030  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Fecal Occult Testing Market size was valued at US$ 165.3 million in 2023 and is poised to grow at a significant CAGR of 5.2% from 2024-2030. Fecal occult blood tests (FOBTs) for colorectal cancer screening are available in a variety of forms. New fecal occult blood tests have the potential to increase colorectal cancer detection and decrease mortality rates. In the Western world, colorectal cancer (CRC) is the most common type of cancer and a primary cause of cancer death. The incidence rate rises dramatically beyond the age of 50, and the estimated lifetime risk of CRC is 5 to 6 percent. A little over 75% of new cases include those at average risk.

According to personal communication, approximately a million new CRC cases are anticipated globally in 2001, with a yearly age-adjusted incidence rate of 57 per 100,000 people. Over the past ten years, survival has remained basically unchanged despite improvements in detection, surgical treatment, and adjuvant chemotherapy. The majority of colorectal cancers are sporadic, and a good prognosis is correlated with the early identification and removal of these lesions.

summary download arrow Download Free Sample

Fecal Occult Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.2%

Largest Market

North-America

Fastest Growing Market

North-America

Fecal Occult Testing Market Dynamics

Colorectal cancer (CRC) is already the third leading cause of cancer death in the world, and its incidence is steadily rising in developing nations. Also known as colorectal adenocarcinoma, CRC usually emerges from the glandular, epithelial cells of the large intestine. Cancer arises when certain cells of the epithelium acquire a series of genetic or epigenetic mutations that confer on them a selective advantage. With abnormally heightened replication and survival, these hyper-proliferative cells give rise to a benign adenoma, which may then evolve into carcinoma and metastasize over decades. Colorectal cancer is the third most common cancer diagnosed in both men and women each year in the United States, excluding skin cancer. In 2022, an estimated 151,030 adults in the United States will be diagnosed with colorectal cancer.

These numbers include 106,180 new cases of colon cancer (54,040 men and 52,140 women) and 44,850 new cases of rectal cancer (26,650 men and 18,200 women). Worldwide, colorectal cancer is the third most diagnosed cancer. An estimated 1,880,725 people were diagnosed with colorectal cancer in 2020. These numbers include 1,148,515 colon cancer cases and 732,210 rectal cancer cases. Diagnosis of colon cancer at an early stage can help in controlling mortality. Availability of fecal occult blood test products in online stores and improvement in direct-to-consumer laboratory testing are the trending factors expected to provide lucrative growth opportunities to the fecal occult testing market during the forecast period.

Fecal Occult Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 165.3 million

Market CAGR

5.2%

By Product

  • Guaiac FOB Stool Test
  • Immuno-FOB Agglutination Test
  • Lateral Flow Immuno-FOB Test
  • Immuno-FOB ELISA Test

By End User

  • Hospitals
  • Clinical Diagnostic Laboratories
  • Physicians' Office Laboratories

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The fecal occult testing market report provides granular level information about the Market size, regional Market share, historic Market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key Market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the Market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the Market.
  • The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The fecal occult testing market size was valued at US$ 165.3 million in 2023 and is set to grow at a significant CAGR of 5.2% from 2024-2030.

Epigenomics AG, Beckman Coulter Inc., Abbott Laboratories, Biohit Oyj., Polymedco CDP LLC

North America is the fastest-growing region in the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Fecal Occult Testing Market Introduction 
2.1.Global Fecal Occult Testing Market  - Taxonomy
2.2.Global Fecal Occult Testing Market  - Definitions
2.2.1. By Product Type 
2.2.2. By End User
2.2.3. By Region
3.Global Fecal Occult Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Fecal Occult Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Fecal Occult Testing Market  By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Guaiac FOB Stool Test
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Immuno-FOB Agglutination Test
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Lateral Flow Immuno-FOB Test
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Immuno-FOB ELISA Test
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Fecal Occult Testing Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Clinical Diagnostic Laboratories
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Physicians' Office Laboratories
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Fecal Occult Testing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Fecal Occult Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Guaiac FOB Stool Test
8.1.2.Immuno-FOB Agglutination Test
8.1.3.Lateral Flow Immuno-FOB Test
8.1.4.Immuno-FOB ELISA Test
8.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Clinical Diagnostic Laboratories
8.2.3.Physicians' Office Laboratories
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Fecal Occult Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Guaiac FOB Stool Test
9.1.2.Immuno-FOB Agglutination Test
9.1.3.Lateral Flow Immuno-FOB Test
9.1.4.Immuno-FOB ELISA Test
9.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Clinical Diagnostic Laboratories
9.2.3.Physicians' Office Laboratories
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Fecal Occult Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Guaiac FOB Stool Test
10.1.2.Immuno-FOB Agglutination Test
10.1.3.Lateral Flow Immuno-FOB Test
10.1.4.Immuno-FOB ELISA Test
10.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Clinical Diagnostic Laboratories
10.2.3.Physicians' Office Laboratories
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Fecal Occult Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Guaiac FOB Stool Test
11.1.2.Immuno-FOB Agglutination Test
11.1.3.Lateral Flow Immuno-FOB Test
11.1.4.Immuno-FOB ELISA Test
11.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Clinical Diagnostic Laboratories
11.2.3.Physicians' Office Laboratories
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Fecal Occult Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Guaiac FOB Stool Test
12.1.2.Immuno-FOB Agglutination Test
12.1.3.Lateral Flow Immuno-FOB Test
12.1.4.Immuno-FOB ELISA Test
12.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Clinical Diagnostic Laboratories
12.2.3.Physicians' Office Laboratories
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Quidel Corporation
13.2.2.EIKEN CHEMICAL CO.LTD.
13.2.3.Epigenomics AG
13.2.4.Beckman Coulter Inc.
13.2.5.Abbott Laboratories
13.2.6.Biohit Oyj.
13.2.7.Polymedco CDP LLC
13.2.8.Quest Diagnostics Incorporated
13.2.9.Randox Laboratories Ltd.
13.2.10.EDP Biotech
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Quidel Corporation
  • EIKEN CHEMICAL CO.LTD.
  • Epigenomics AG
  • Beckman Coulter Inc.
  • Abbott Laboratories
  • Biohit Oyj.
  • Polymedco CDP LLC
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • EDP Biotech

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market